1 / 13

Vulval Dermatology

Vulval Dermatology. Update from British Society for Study of Vulval Diseases Meeting Cardiff 2008. BSSVD. Relief of patients suffering from vulval disease Promotion of research into causes of vulval disease Practice and art and science of diagnosis and treatment of vulval diseases

toki
Download Presentation

Vulval Dermatology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Vulval Dermatology Update from British Society for Study of Vulval Diseases Meeting Cardiff 2008

  2. BSSVD • Relief of patients suffering from vulval disease • Promotion of research into causes of vulval disease • Practice and art and science of diagnosis and treatment of vulval diseases • www.bssvd.org

  3. Cardiff 2008 • Current Challenges in Vulval disease • Prospective Study to Determine Factors Leading to Delayed presentation of Patients with Vulval Lichen Sclerosis AJ Mehta et al University Hospital Wales

  4. Background • LS is chronic ,inflammatory condition • Most commonly affects post-menopausal women but occurs at all ages • Significant morbidity due to chronicity, scarring,psychosexual problems and SCC risk

  5. Prospective study of 28 post menopausal patients with LS in dermatology OPD

  6. Results • Mean duration of symptoms 99 months • Most common symptom itching in 96% • Burning on micturition in 50% • 50% tried OTC treatments before seeing GP

  7. Results • 60% waited >3/12 to report symptoms • 21% waited 4-6/12 • 14% 7-12/12 • 25%>12/12

  8. Why did they wait? • 42% patients thought symptoms were “normal for their age” • 21% too embarrassed • 71% pts would prefer female Dr • Other reasons:other health problems or family members took precedence

  9. 76% patients examined by GP • 32% given definite diagnosis (7% candida) • Of those pts with no definite diagnosis • 25% referred immediately to dermatology • 25% ref after 1-3/12 • 14% ref after 4-6/12 • 11% ref after7-12/12

  10. Conclusions • Increased patient awareness required • Vulval Health Awareness Campaign • www.vhac.org • Education re self examination • Increased clinician awareness

  11. Information Resources for Patients and Dr’s • www.vahc.org • www.bssvd.org • www.vulvalpainsociety.org • www.lichensclerosus.org • www.UKLP.org.uk • www.bashh

  12. Clinical snippets • Vulval ulceration secondary to nicorandil • May occur in pts on long standing treatment and after dosage increase

  13. Clinical Snippets • Increased auto-immunity in association with Lichen sclerosus and erosive Lichen planus • Thyroid disease most common (15% pts) • Coeliac disease associated with erosive LP

More Related